Skip to main content
NEO logo

NeoGenomics, Inc.

NEONASDAQHealthcareDiagnostics & Research

$16.39Today:- (-)1Y +56.84%

As of Oct 22, 2026 close

Market cap
$428.86M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.07$20.15
Volume (live)
-
Avg. volume (3M)
2.26M

NeoGenomics, Inc. (NEO) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for NeoGenomics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy
Based on 12 unique analysts
(18 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$21.50
+31.18% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NEO Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Lu Li
BofA Securities
HoldMaintains
-
Lu Li
UBS
HoldMaintains
-
Bruce Jackson
StoneX
BuyMaintains
$16.00 → $20.00
Matt Larew
William Blair
HoldMaintains
-
David Westenberg
Piper Sandler
BuyMaintains
$21.00
Mark Massaro
BTIG
BuyUpgrades
$28.00
Michael Matson
Needham
BuyReiterates
$19.00 → $22.00
Shrabana Mukherjee
TopStockAnalysts
BuyInitiates Coverage
-
Zacks Equity Research
Zacks Equity Research
BuyInitiates Coverage
-
Ekta Bagri
Zacks Equity Research
BuyInitiates Coverage
-
Matt Larew
William Blair
HoldReiterates
-
David Westenberg
Piper Sandler
BuyMaintains
$21.00
William Bonello
Craig-Hallum
BuyMaintains
$17.00 → $19.00
Mark Massaro
BTIG
HoldReiterates
-
Daniel Brennan
TD Cowen
BuyMaintains
$19.00
Michael Matson
Needham
BuyReiterates
$15.00 → $19.00
Mark Massaro
BTIG
HoldReiterates
-
Daniel Brennan
TD Cowen
BuyMaintains
$19.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 8, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for NEO?

The analyst consensus rating for NEO is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for NEO?

The average 12-month price target for NEO is $21.50, representing an upside of 31.2% from the Oct 22, 2026 close of $16.39.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.